The Loyalty Paradox

4.91 stars on the App Store. 85 out of 100 on the American Customer Satisfaction Index. Number one online retailer in customer satisfaction, three years running. And down 57% from its high.

Last November, a woman in Austin whose golden retriever had died the week before received a package from Chewy. Inside was a hand-painted oil portrait of her dog, a sympathy card signed by a customer service agent, and a full refund on the last bag of food she had ordered. She had not asked for any of it.

She posted a photo on TikTok. It got 2.3 million views. In the comments, hundreds of people shared their own Chewy stories. The company sends roughly a thousand hand-painted pet portraits every week. It has for years.

That same month, Chewy's stock was at $35 and falling. By March 2026, it would report $12.6 billion in revenue, $562 million in free cash flow, and its strongest adjusted EBITDA in company history. The stock dropped 16% on the earnings print anyway.

I am telling you this because today, May 27, 2026, Chewy is a company where the customer experience and the stock chart exist in different universes. The customers have never been more loyal. The stock has never been cheaper relative to the business underneath it.

Keep up with every Chewy catalyst as it lands → calendar.turnaroundradar.com

The decline narrative has nothing to do with the product.

Chewy went public at $22 in June 2019. The pandemic hit. Pet adoption surged. By February 2021, the stock was $120. Sumit Singh, the CEO who had been running the company since 2018, built the Autoship subscription engine to 78% of net sales, introduced pet pharmacy, and turned Chewy from a dog-food delivery company into a recurring-revenue platform. By early 2025, the stock had settled around $30 after a bumpy post-pandemic normalization. Then it rallied to $48.62 on the strength of four consecutive quarters of 8%+ revenue growth and record free cash flow.

Then five things happened at once.

First, BC Partners — the private equity firm that still controls 91.8% of Chewy's voting power through a dual-class structure — conducted secondary share offerings, adding selling pressure that the float could not absorb.

Second, the stock ran too far too fast. At $48, Chewy was priced for growth acceleration that had not yet materialized.

Third, tariff uncertainty hit the entire consumer discretionary sector. CEO Singh, on the May 2026 earnings call, used the phrase that sinks stocks: he said U.S. consumers were feeling "stretched."

Fourth, Tractor Supply reported weakness in its companion animal segment, raising fears of a broader pet spending slowdown. The contagion was sector-wide and indiscriminate.

Fifth, on May 8, 2026, the California Attorney General unsealed evidence in a price-fixing case alleging that Chewy, Amazon, Walmart, Home Depot, and Best Buy had coordinated with a vendor called GlobalOne to fix pet treat prices. The stock fell 7.67% in a single session. The trial is set for January 2027.

None of these five catalysts say anything about customer satisfaction. None of them say anything about whether people love the product. The stock is down 57% because of capital structure, macro rotation, sector contagion, and legal risk.

That is how Chewy got to $20.

The revenue, margin, EBITDA, and free cash flow lines are all moving in the right direction. The net income decline looks alarming until you notice that stock-based compensation hit $311 million in FY2025. Strip out SBC and the business is more profitable than ever.

The FY2026 guidance is $13.6 billion to $13.75 billion in revenue, 8 to 9% growth, with adjusted EBITDA margins of 6.6 to 6.8%. Management called Q1 FY2026 the "low point" for the year, guiding EPS of $0.40 to $0.45 for the quarter.

The strategic pipeline includes three moves worth tracking. On April 8, Chewy announced the acquisition of Modern Animal, a tech-forward veterinary platform with 29 clinics, 100,000 member families, and $125 million in annualized revenue. The clinics generate twice the industry-average revenue per location with 20%+ EBITDA margins at maturity. Chewy already operates 18 vet clinics. The acquisition takes the footprint to 47 locations, turning Chewy Health from a pharmacy-only business into a vertically integrated pet healthcare platform.

The second move is private brands. Under the name "Chewy Made," the company is targeting mid-teens penetration of net sales at gross margins substantially above national brands.

The third is what Singh calls "Agentic Commerce" — an AI-driven discovery layer that surfaces products based on behavioral signals rather than search queries. Whether this delivers revenue in the next four quarters is unknown. That it signals strategic ambition rather than cost-cutting retreat is the point.

Twenty analysts rate the stock a Buy. None rate it Sell. The median 12-month target is $41, implying 98% upside from current levels.

Triangulation rule: A finding enters this report only if three or more independent channels point the same direction.

The headline numbers look exceptional. iOS App Store 4.91 out of 5 from 1.1 million ratings. ACSI number one. ResellerRatings 4.88 out of 5. But those platforms overweight satisfied customers — the people who tap five stars after a smooth Autoship delivery. The platforms where dissatisfied customers go tell a different story.

Test 1 — Is Chewy's 1-star tail abnormally high?

Trustpilot, which skews toward complaint-motivated reviewers, shows a 1-star rate of 16.0% across 13,071 reviews. The industry baseline for a well-rated e-commerce retailer is approximately 10%.

Chewy's 1-star tail is 60% above the industry baseline, and the result is statistically significant at any conventional threshold. The gap is real.

Test 2 — The U-shape: is the polarization structural?

On ConsumerAffairs, where we have clean per-star distribution data across 3,202 reviews, 91.3% of all reviews fall at the extremes — either 5-star or 1-star. Only 8.7% fall in the middle (2, 3, or 4 stars). The polarization ratio is 10.6x (extremes to middle).

A chi-square goodness-of-fit test against a uniform distribution rejects at p < 0.001 (chi-square = 4,264.1). This is not a normal distribution compressed by scale. It is a bimodal distribution: the customer experience is either excellent or terrible, with almost nothing in between.

What the U-shape means: Chewy does not have a mediocre product. It has an excellent product with an operational failure mode. The 1-star tail is driven overwhelmingly by three complaint types: FedEx delivery failures (lost packages, damaged goods), Autoship billing issues (charged after cancellation, price changes without notification), and pharmacy processing delays. When the logistics and billing work — which is 76 to 84% of the time — customers love it. When they break, customers are furious.

This is a fixable problem. It is not a brand problem or a demand problem. It is an operations problem.

Chewy's employees tell two different stories depending on which platform they use.

On Glassdoor, where reviews skew toward office, engineering, and corporate roles, Chewy scores 3.4 out of 5 from 3,909 reviews. CEO Sumit Singh has 61% approval. 54% would recommend the company to a friend.

On Indeed, where reviews skew toward warehouse, fulfillment, and customer service roles, Chewy scores 2.8 out of 5 from 3,847 reviews. Management scores 2.3 out of 5 — the lowest sub-score on the platform.

A Welch's t-test on the overall ratings yields t = 19.55, p < 0.001. The 0.6-star gap is not noise.

The pattern matches the customer U-shape. The office experience is decent. The frontline experience is strained. Recent Glassdoor reviews cite RTO mandates (3 days per week, even when team members are in different offices), AI-driven performance metrics that penalize agents when specific keywords are not detected by automated systems, and a management culture increasingly described as "former Amazon."

Chewy laid off 674 employees in March 2025, primarily in Dallas operations. Multiple reviews describe the RTO mandate as a stealth reduction-in-force strategy.

The employee data does not show a company in crisis. It shows a company under cost pressure, squeezing the frontline to deliver margins that the market is not rewarding.

The financials show a company growing revenue 8%, generating record free cash flow, and expanding into veterinary care with a $125-million-revenue acquisition. They do not show that the experience of using Chewy as a customer is bimodal rather than uniformly good.

They do not show that 16% of Trustpilot reviewers — 2,091 people who cared enough to write a review — are furious, almost always about logistics and billing rather than the core product.

They do not show that the frontline employees delivering that customer experience rate their management 2.3 out of 5.

And they do not show the legal risk sitting six months away. The California antitrust trial in January 2027, if it goes badly, could impose fines, tighter pricing rules, and lasting reputational damage. The market has partially priced this in — the 7.67% drop on the unsealing was real — but it has not priced in the outcome.

Recovering:

Not recovering:

Unknown:

The statistical tests in this report use published aggregate data from Trustpilot, ConsumerAffairs, Glassdoor, and Indeed. Per-review time-series data was not available for Chewy on Trustpilot (reviews are paginated and JavaScript-rendered). The trend tests that Turnaround Radar ran on PTON's BBB data could not be replicated here because BBB shows only 218 complaints over 12 months, insufficient for a powered monthly trend test.

The 1-star tail Z-test uses a 10% industry baseline estimated from comparable e-commerce retailers. This baseline is not an audited benchmark. The result (Z = 13.26) is robust to significant variation in the baseline — even at 14%, the Z-score exceeds 3.0.

The employee platform divergence analysis uses estimated standard deviations (1.3 for Glassdoor, 1.4 for Indeed) based on typical rating distributions. The actual standard deviations are not published by either platform. The result (t = 19.55) is robust to reasonable variation in the assumed standard deviations.

The ACSI score of 85 is from the 2025 annual study. The 2026 study has not been published.

The bear case is simple: the stock is down 57% and still falling, the antitrust trial creates binary risk in January, BC Partners can sell more shares at any time, the CEO himself said consumers are "stretched," and the YTD trend is relentlessly negative.

The bull case is also simple: Chewy is the number one rated online retailer in America, growing revenue 8%, generating $562 million in free cash flow, expanding into the $32 billion pet healthcare market, and trading at a 98% discount to analyst consensus. Every competitor is in worse shape. The product is loved. The moat is real.

Probability-weighted expected 12-month return: +42% to +58%.

Now ($20.73, May 27, 2026): The stock is below its IPO price despite generating 5x the revenue and 10x the free cash flow it had at IPO. Chewy+ membership is at 3% of sales. Autoship is at 83%. The pet portrait machine is still running. The business is not broken. The price is broken.

Position sizing depends on legal risk tolerance. If you can stomach the January 2027 antitrust trial uncertainty, the current price offers asymmetric upside. Start at 1 to 2% of portfolio.

June 10, 2026 (Q1 FY2026 earnings): This is the first validation checkpoint. Management guided EPS of $0.40 to $0.45. The print needs to show: (a) active customer growth maintained, (b) Autoship penetration stable or rising, (c) commentary on the antitrust case, and (d) Modern Animal integration progress. If the print is clean, add to 2 to 3%.

Q2 FY2026 (August-September 2026): Modern Animal close expected. The revenue contribution starts here. If the integration is on track, the Chewy Health narrative shifts from pharmacy-only to integrated vet care. The stock re-rates.

January 2027 (antitrust trial): This is the decider. If the ruling is favorable or the case settles, the legal overhang lifts and the stock has a clear path to $35+. If the ruling is adverse, trim to 1% and reassess the magnitude of fines and operating restrictions.

The next catalyst is 14 days away. On June 10, 2026, Chewy reports Q1 FY2026. Within 24 hours of that print, Turnaround Radar subscribers get the follow-up: did Singh reaffirm the 8 to 9% growth guide? What did NSPAC do? Did the antitrust case come up in the Q&A? Is Modern Animal closing on schedule? Am I sizing up to 3%, or standing pat?

Same drill in August when the Modern Animal close lands. Same drill in January when the antitrust trial starts. Every catalyst on the ladder gets its own update.

If you want the June 10 read in your inbox the morning it lands, subscribe below. The setup we have laid out only pays if you act on the right catalyst — and the right catalyst is the one with a date attached.

Track every dated catalyst → calendar.turnaroundradar.com

Turnaround Radar covers consumer brand stocks trading 30%+ below their 52-week highs, distinguishing real recoveries from value traps. This is issue #11.

This is research, not investment advice. The author does not own CHWY at time of publication.